Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

41.20
Delayed Data
As of May 26
 +0.32 / +0.78%
Today’s Change
27.53
Today|||52-Week Range
43.62
+2.49%
Year-to-Date

Today’s Trading

Previous close40.88
Today’s open40.88
Day’s range40.72 - 41.38
Volume211,087
Average volume (3 months)354,933
Market cap$2.1B
Dividend yield--
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+53.21%
Earnings growth (this year)+4.87%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)-2.68%
P/E ratio132.9
Price/Sales2.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PODDInsulet Corp+0.12+0.28%
INGNInogen Inc-1.02-1.15%
HYHHalyard Health Inc-0.02-0.06%
MMSIMerit Medical System...+0.45+1.31%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.32
Annual revenue (last year)$886.1M
Annual profit (last year)-$26.3M
Net profit margin-2.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts